TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals. (2008)
Attributed to:
Adult HIV Clinical Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/QAD.0b013e3282f511f1
PubMed Identifier: 18356603
Publication URI: http://europepmc.org/abstract/MED/18356603
Type: Journal Article/Review
Volume: 22
Parent Publication: AIDS (London, England)
Issue: 6
ISSN: 0269-9370